{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T00:35:01Z","timestamp":1784334901973,"version":"3.55.0"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2014,4,9]],"date-time":"2014-04-09T00:00:00Z","timestamp":1397001600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,4,9]]},"abstract":"<jats:title>Summary<\/jats:title>\n               <jats:p>Numerous studies suggest that high levels of circulating immunoglobulin (Ig)A tissue transglutaminase (TTG2) antibodies predict coeliac disease with high specificity. Accordingly, it has been suggested that duodenal biopsy may not be required routinely for diagnostic confirmation where quantitative serology identifies the presence of high antibody titres. However, defining a cut-off TTG2 threshold is problematic, as the multiple available assay methods are not harmonized and most studies have been focused on the paediatric population. Recent paediatric guidelines proposed a TTG2 antibody diagnostic cut-off at 10\u2009\u00d7\u2009the upper limit of normal (ULN) for the method; however, concerns remain about errors of generalization, between both methods and laboratories. In this study, we used retrospective laboratory data to investigate the relationship between TTG2 antibody levels and Marsh 3 histology in the seropositive population of adults and children at a single centre. Among 202 seropositive patients with corresponding biopsies, it was possible to define a TTG2 antibody cut-off with 100% specificity for Marsh 3 histology, at just over 10\u2009\u00d7\u2009ULN for the method. However, UK National External Quality Assurance Scheme returns during the study period showed a wide dispersion of results and poor consensus, both between methods and between laboratories using the same method. Our results support the view that high-titre TTG2 antibody levels have strong predictive value for villous atrophy in adults and children, but suggest that decision cut-offs to guide biopsy requirement will require local validation. TTG2 antibody assay harmonization is a priority, in order to meet the evolving requirements of laboratory users in this field.<\/jats:p>","DOI":"10.1111\/cei.12249","type":"journal-article","created":{"date-parts":[[2013,12,11]],"date-time":"2013-12-11T08:26:59Z","timestamp":1386750419000},"page":"190-198","source":"Crossref","is-referenced-by-count":50,"title":["High-titre circulating tissue transglutaminase-2 antibodies predict small bowel villous atrophy, but decision cut-off limits must be locally validated"],"prefix":"10.1093","volume":"176","author":[{"given":"L","family":"Beltran","sequence":"first","affiliation":[{"name":"Department of Biochemistry and Immunology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Koenig","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Egner","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Howard","sequence":"additional","affiliation":[{"name":"Department of Histopathology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Butt","sequence":"additional","affiliation":[{"name":"Department of Paediatric Gastroenterology and Nutrition, Royal Alexandra Children's Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Austin","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Immunology Protein Reference Unit and UK NEQAS for Immunology, Immunochemistry & Allergy, Northern General Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R R","family":"Sanderson","sequence":"additional","affiliation":[{"name":"Department of Immunology Protein Reference Unit and UK NEQAS for Immunology, Immunochemistry & Allergy, Northern General Hospital, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Goubet","sequence":"additional","affiliation":[{"name":"Department of Clinical Investigation and Research Unit, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Saleh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lavender","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Stainer","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Royal Sussex County Hospital, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M D","family":"Tarzi","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Immunology, Royal Sussex County Hospital, Brighton, UK"},{"name":"Brighton and Sussex Medical School, University of Sussex, Brighton, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2014,4,9]]},"reference":[{"key":"2021122010024426300_cei12249-bib-0001","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1038\/ajg.2010.276","article-title":"Update on serologic testing in celiac disease","volume":"105","author":"Leffler","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"2021122010024426300_cei12249-bib-0002","doi-asserted-by":"crossref","first-page":"b1684","DOI":"10.1136\/bmj.b1684","article-title":"Recognition and assessment of coeliac disease in children and adults: summary of NICE guidance","volume":"338","author":"Richey","year":"2009","journal-title":"BMJ"},{"key":"2021122010024426300_cei12249-bib-0003","article-title":"The management of adults with coeliac disease","volume-title":"British Society of Gastroenterology Guidelines","author":"Ciclitira"},{"key":"2021122010024426300_cei12249-bib-0004","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.bpg.2005.02.006","article-title":"Diagnosis of coeliac disease","volume":"19","author":"Green","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"2021122010024426300_cei12249-bib-0005","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/MCG.0b013e31802e70b1","article-title":"Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease","volume":"42","author":"Donaldson","year":"2008","journal-title":"J Clin Gastroenterol"},{"key":"2021122010024426300_cei12249-bib-0006","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1111\/j.1365-2036.2008.03609.x","article-title":"Coeliac disease: a biopsy is not always necessary for diagnosis","volume":"27","author":"Hill","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"2021122010024426300_cei12249-bib-0007","doi-asserted-by":"crossref","first-page":"4775","DOI":"10.3748\/wjg.15.4775","article-title":"Duodenal biopsy may be avoided when high transglutaminase antibody titers are present","volume":"15","author":"Vivas","year":"2009","journal-title":"World J Gastroenterol"},{"key":"2021122010024426300_cei12249-bib-0008","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MPG.0b013e3181a81384","article-title":"Prediction of clinical and mucosal severity of coeliac disease and dermatitis herpetiformis by quantification of IgA\/IgG serum antibodies to tissue transglutaminase","volume":"50","author":"Dahlbom","year":"2010","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021122010024426300_cei12249-bib-0009","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.dld.2011.10.013","article-title":"High tissue-transglutaminase antibody level predicts small intestinal villous atrophy in adult patients at high risk of celiac disease","volume":"44","author":"Zanini","year":"2011","journal-title":"Dig Liver Dis"},{"key":"2021122010024426300_cei12249-bib-0010","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.3748\/wjg.v18.i32.4399","article-title":"Tissue transglutaminase levels above 100\u2009U\/mL and celiac disease: a prospective study","volume":"18","author":"Mubarak","year":"2012","journal-title":"World J Gastroenterol"},{"key":"2021122010024426300_cei12249-bib-0011","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/intimm\/dxs159","article-title":"Anti-transglutaminase immunoreactivity and histological lesions of the duodenum in coeliac patients","volume":"25","author":"Nenna","year":"2013","journal-title":"Int Immunol"},{"key":"2021122010024426300_cei12249-bib-0012","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021122010024426300_cei12249-bib-0013","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1136\/archdischild-2013-303996","article-title":"Joint BSPGHAN and Coeliac UK guidelines for the diagnosis and management of coeliac disease in children","volume":"98","author":"Murch","year":"2013","journal-title":"Arch Dis Child"},{"key":"2021122010024426300_cei12249-bib-0014","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1097\/MPG.0b013e31826531f6","article-title":"ESPGHAN guidance on coeliac disease 2012: multiples of ULN for decision making do not harmonise assay performance across centres","volume":"55","author":"Egner","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021122010024426300_cei12249-bib-0015","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.cgh.2012.10.025","article-title":"Defining thresholds of antibody levels improves diagnosis of celiac disease","volume":"11","author":"Vermeersch","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2021122010024426300_cei12249-bib-0016","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MPG.0b013e318216f2e5","article-title":"Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report","volume":"54","author":"Giersiepen","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021122010024426300_cei12249-bib-0017","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/MPG.0b013e318279887b","article-title":"Celiac disease: the new proposed ESPGHAN diagnostic criteria do work well in a selected population","volume":"56","author":"Klapp","year":"2013","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2021122010024426300_cei12249-bib-0018","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.prp.2012.01.008","article-title":"Tricks of the trade: how to avoid histological pitfalls in celiac disease","volume":"208","author":"Ravelli","year":"2012","journal-title":"Pathol Res Pract"},{"key":"2021122010024426300_cei12249-bib-0019","first-page":"S53","article-title":"Basics of estimating measurement uncertainty","volume":"29","author":"White","year":"2008","journal-title":"Clin Biochem Rev"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcei.12249","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/176\/2\/190\/41789956\/cei12249.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/176\/2\/190\/41789956\/cei12249.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T16:25:47Z","timestamp":1641054347000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/176\/2\/190\/6421210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,4,9]]},"references-count":19,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,4,9]]},"published-print":{"date-parts":[[2014,4,9]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.12249","relation":{},"ISSN":["1365-2249","0009-9104"],"issn-type":[{"value":"1365-2249","type":"electronic"},{"value":"0009-9104","type":"print"}],"subject":[],"published-other":{"date-parts":[[2014,5]]},"published":{"date-parts":[[2014,4,9]]}}}